NATTO: BOARD MEMBERS OF NATTOPHARMA ASA EXERCISE OPTIONS
Oslo, Norway (29 April 2020) - Stefan Halden and Annette Elmqvist, both serving as board members in NattoPharma ASA, has exercised options granted to them in the Annual General Meeting in 2018.
Following the exercise of the option Mr. Halden will hold 133,800 shares and 50,000 options and Mrs. Elmqvist will hold 50,000 shares and 50,000 options in NattoPharma ASA
Based on the power of attorney granted at the annual general meeting of NattoPharma ASA on May 29, 2019, the Board of Directors of NattoPharma has in board proceedings April 29th, 2020 approved a share issue of 100 000 new shares, each with a face value of NOK 3 per share.
Price to be paid for each share is NOK 9,00 per share. The share issue is expected to be completed within end of May 2020.
As a result, the share capital will be increased by NOK 300 000. After completing the share issue the Company’s new share capital will be NOK 58 544 799 divided into 19 514 933 shares, each with a face value of NOK 3.
For more information, please contact:
Kjetil Ramsøy, CEO, NattoPharma, kjetil.ramsoy@nattopharma.com
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.